S. Nayak

发表

Remdesivir for the Treatment of Covid-19 — Final Report

L. Dodd, R. Paredes, H. Lane, 2020, The New England journal of medicine.

No significant differences in nephrotoxicity for tenofovir combined with ritonavir-boosted protease inhibitors in treatment of adult HIV infection

R. Amdur, S. Nayak, V. Kan, 2014 .

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19

Cameron R. Wolfe, A. Amin, M. Proschan, 2020, The New England journal of medicine.

Safety and Pharmacokinetics of XOMA 3AB, a Novel Mixture of Three Monoclonal Antibodies against Botulinum Toxin A

J. Zenilman, E. Fuchs, C. Hendrix, 2014, Antimicrobial Agents and Chemotherapy.

Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-blind, randomised, placebo-controlled, phase 3 trial

Michael R. Wierzbicki, Tom M. Conrad, Cameron R. Wolfe, 2021, The Lancet Respiratory Medicine.

Cryptococcal Meningitis in an HIV-Positive Pregnant Woman

R. Talwani, S. Nayak, B. Gilliam, 2011, Journal of the International Association of Physicians in AIDS Care.

Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial

Catharine I Paules, R. Hyzy, M. Proschan, 2022, The Lancet Respiratory Medicine.

Homologous and Heterologous Covid-19 Booster Vaccinations

D. Montefiori, R. Coler, P. Roberts, 2022, The New England journal of medicine.

SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary Analyses

Michael John Smith, E. Walsh, A. Falsey, 2022, medRxiv.

A Phase 1 Pharmacokinetic and Safety Study of Extended-Duration, High-dose Cefixime for Cephalosporin-resistant Neisseria gonorrhoeae in the Pharynx

M. Golden, J. Zenilman, J. Griffiss, 2018, Sexually transmitted diseases.

Cryptococcus neoformans Prosthetic Joint Infection: Case Report and Review of the Literature

S. Shoham, S. Nayak, N. Shah, 2014, Mycopathologia.

Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants

J. Mascola, R. Baric, E. Boritz, 2021, Science.

Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant

Diane J Post, D. Montefiori, D. Szydlo, 2022, Cell Reports Medicine.

Disease Resurgence, Production Capability Issues and Safety Concerns in the Context of an Aging Population: Is There a Need for a New Yellow Fever Vaccine?

M. Challberg, K. Tomashek, S. Nayak, 2019, Vaccines.

Heterologous SARS-CoV-2 Booster Vaccinations – Preliminary Report

D. Montefiori, D. Szydlo, P. Roberts, 2021, medRxiv.

Graying of the HIV epidemic: a challenge for inpatient medicine providers

C. Harris, S. Nayak, Flora Kisuule, 2015, Journal of community hospital internal medicine perspectives.

Temporal Improvements in COVID-19 Outcomes for Hospitalized Adults: A Post Hoc Observational Study of Remdesivir Group Participants in the Adaptive COVID-19 Treatment Trial

Cameron R. Wolfe, G. E. Potter, R. Davey, 2022, Annals of Internal Medicine.

Post hoc analysis of a randomized placebo-controlled pilot study on the effect of Amphora®, an acid-buffering vaginal gel, on vaginal pH by baseline vaginal pH level

J. Griffiss, S. Nayak, D. Friend, 2018, Fertility and Sterility.

Phase 1 clinical trials of DAS181, an inhaled sialidase, in healthy adults.

J. Zenilman, E. Fuchs, C. Hendrix, 2015, Antiviral research.

Procalcitonin-Guided Antibiotic Therapy Reduces Antibiotic Use for Lower Respiratory Tract Infections in a United States Medical Center: Results of a Clinical Trial

P. Galiatsatos, M. Masterson, S. Nayak, 2018, Open forum infectious diseases.

Safety and microbiological activity of phage therapy in persons with cystic fibrosis colonized with Pseudomonas aeruginosa: study protocol for a phase 1b/2, multicenter, randomized, double-blind, placebo-controlled trial

R. Schooley, P. Tamma, D. Conrad, 2022, Trials.

Greater HIV Testing After Veterans Health Administration Policy Change: The Experience from a VA Medical Center in a High HIV Prevalence Area

S. Nayak, Virginia L Kan, Seema U Nayak, 2012, Journal of acquired immune deficiency syndromes.

Prevalence of Asymptomatic Bacterial Sexually Transmitted Infections in Hospitalized HIV Patients in Baltimore City

S. Nayak, M. Charurat, L. Vaughan, 2012, Journal of the International Association of Physicians in AIDS Care.

Isolation of Leclercia adecarboxylata from a wound infection after exposure to hurricane-related floodwater

Vernissia Tam, S. Nayak, 2012, BMJ Case Reports.

Safety, Tolerability, Systemic Exposure, and Metabolism of CRS3123, a Methionyl-tRNA Synthetase Inhibitor Developed for Treatment of Clostridium difficile, in a Phase 1 Study

T. Jarvis, N. Janjić, J. Zenilman, 2017, Antimicrobial Agents and Chemotherapy.

Bivalent and Monovalent SARS-CoV-2 Variant Vaccine Boosters Improve coverage of the known Antigenic Landscape: Results of the COVID-19 Variant Immunologic Landscape (COVAIL) Trial

A. Falsey, D. Montefiori, S. Little, 2023, Research square.

Myocarditis after trimethoprim/sulfamethoxazole treatment for ehrlichiosis.

G. Simon, S. Nayak, 2013, Emerging infectious diseases.

Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial

K. Schmader, E. Walsh, A. Falsey, 2023, Nature Medicine.

Comparison of DNA Sequencing and Multispecific Monoclonal Antibody (Msmab-1) based Immunohistochemical Detection of IDH1/2 Mutation in Acute Myeloid Leukemia Cases.

S. Nayak, Ashutosh Kumar, R. Kushwaha, 2023, International Journal of Medical Science And Diagnosis Research.

Cryptococcus neoformans Prosthetic Joint Infection: Case Report and Review of the Literature

S. Shoham, S. Nayak, N. Shah, 2014, Mycopathologia.

Klebsiella oxytoca bacteremia-causal relationship to symptomatic colitis?

J. Kuruppu, S. Nayak, E. Cox, 2013, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Phase 1 clinical trials of DAS181, an inhaled sialidase, in healthy adults.

J. Zenilman, E. Fuchs, C. Hendrix, 2015, Antiviral research.

Homologous and Heterologous Covid-19 Booster Vaccinations

D. Montefiori, R. Coler, P. Roberts, 2022, New England Journal of Medicine.

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19

Cameron R. Wolfe, A. Amin, M. Proschan, 2020, New England Journal of Medicine.